Price target
431.810.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 26 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
SRPT EPS for the last quarter is 35.45 MXN despite the estimation of 15.61 MXN. In the next quarter EPS is expected to reach −12.80 MXN. Track more of Sarepta Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Sarepta Therapeutics, Inc. revenue is expected to reach 6.19 B MXN. Check out Sarepta Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SRPT price target is 431.81 MXN with a max estimate of 1,476.83 MXN and a min estimate of 92.30 MXN. Check if this forecast comes true in a year, meanwhile watch Sarepta Therapeutics, Inc. stock price chart and keep track of the current situation with SRPT news and stock market news.
We've gathered opinions of 26 analysts rating SRPT stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.